<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>226(1)</volume><submitter>Dakal TC</submitter><pubmed_abstract>SARS-CoV-2 is a highly contagious virus that has caused serious health crisis world-wide resulting into a pandemic situation. As per the literature, the SARS-CoV-2 is known to exploit humanACE2 receptors (similar toprevious SARS-CoV-1) for gaining entry into the host cell for invasion, infection, multiplication and pathogenesis. However, considering the higher infectivity of SARS-CoV-2 along with the complex etiology and pathophysiological outcomes seen in COVID-19 patients, it seems that there may be an alternate receptor for SARS-CoV-2. I performed comparative protein sequence analysis, database based gene expression profiling, bioinformatics based molecular docking using authentic tools and techniques for unveiling the molecular basis of high infectivity of SARS-CoV-2 as compared to pre</pubmed_abstract><journal>Immunobiology</journal><pagination>152021</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7642744</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>SARS-CoV-2 attachment to host cells is possibly mediated via RGD-integrin interaction in a calcium-dependent manner and suggests pulmonary EDTA chelation therapy as a novel treatment for COVID 19.</pubmed_title><pmcid>PMC7642744</pmcid><pubmed_authors>Dakal TC</pubmed_authors></additional><is_claimable>false</is_claimable><name>SARS-CoV-2 attachment to host cells is possibly mediated via RGD-integrin interaction in a calcium-dependent manner and suggests pulmonary EDTA chelation therapy as a novel treatment for COVID 19.</name><description>SARS-CoV-2 is a highly contagious virus that has caused serious health crisis world-wide resulting into a pandemic situation. As per the literature, the SARS-CoV-2 is known to exploit humanACE2 receptors (similar toprevious SARS-CoV-1) for gaining entry into the host cell for invasion, infection, multiplication and pathogenesis. However, considering the higher infectivity of SARS-CoV-2 along with the complex etiology and pathophysiological outcomes seen in COVID-19 patients, it seems that there may be an alternate receptor for SARS-CoV-2. I performed comparative protein sequence analysis, database based gene expression profiling, bioinformatics based molecular docking using authentic tools and techniques for unveiling the molecular basis of high infectivity of SARS-CoV-2 as compared to pre</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Jan</publication><modification>2026-04-07T23:22:53.207Z</modification><creation>2020-11-19T08:02:48Z</creation></dates><accession>S-EPMC7642744</accession><cross_references><pubmed>33232865</pubmed><doi>10.1016/j.imbio.2020.152021</doi></cross_references></HashMap>